Document is current

Article History

Accepted: 12 September 2024

First Online: 26 September 2024

Declarations

:

: TAG reports Advisory Board—Speaker from Lilly, Bayer and Astellas; Speaker from Eisai, Roche, Ipsen and Adacap; Advisory Board—Speaker—Grant from Johnson & Johnson and Advisory Board from MSD. JMT reports Speaker from Lilly, Eisai and Roche and Advisory Board—Speaker from Deciphera and Pharmamar. IPQ reports Advisory Board from Abbott; Speaker from Bayer, Eisai, Merck and Novarits and Non-financial Support from MSD. JRC reports Advisory Board from Novartis, Sanofi, Merck and Lilly and Speaker from Ipsen. MAV reports Speaker—Grant from Lilly, Roche, Pharmamar and AstraZeneca. JH reports Advisory Board and Speaker from Ipsen, Novartis, Adacap and Eisai; Speaker from Bayer and Angelini and Advisory Board and Speaker from LEO. LID reports Speaker from EISAI and Bayer; Advisory Board—Speaker from Ipsen, Lilly, Merck and BMS and Advisory Board—Speaker—Other from ROCHE and MSD. PJF, NB and MN have nothing to disclose.

: Compliance with ethical standards. The current study has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

: It does not apply the requirement of an informed consent to patients.